{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Severe hypertriglyceridaemia",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_gemfibrozil",
          "name": "Gemfibrozil"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_fenofibrate",
          "name": "Fenofibrate"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_clofibrate",
          "name": "Clofibrate"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_niacin",
          "name": "Niacin"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_estrogens",
          "name": "Estrogens"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_thiazolidinediones",
          "name": "Thiazolidinediones"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_sodium_glucose_cotransporter_2_inhibitors",
          "name": "Sodium-glucose cotransporter-2 inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_bosentan",
          "name": "Bosentan"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_glitazones",
          "name": "Glitazones"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_beta_blockers",
          "name": "Beta-blockers"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_progestins",
          "name": "Progestins"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [
      {
        "hypothesis_id": "H1",
        "score": 0.63,
        "components": {
          "mechanism_fit": 0.85,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.7,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.2
        },
        "graph_signals": {
          "support_weight": 1.55,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Gemfibrozil 已知作用于甘油三酯代谢，并直接与疾病相关"
          ],
          "safety_risk": [
            "未显示明显的安全性风险"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H2",
        "score": 0.64,
        "components": {
          "mechanism_fit": 0.85,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.7,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.2
        },
        "graph_signals": {
          "support_weight": 1.55,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Fenofibrate 已知作用于甘油三酯代谢，并直接与疾病相关"
          ],
          "safety_risk": [
            "未显示明显的安全性风险"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H3",
        "score": 0.6,
        "components": {
          "mechanism_fit": 0.8,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.7,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.2
        },
        "graph_signals": {
          "support_weight": 1.45,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Clofibrate 已知作用于甘油三酯代谢，并直接与疾病相关"
          ],
          "safety_risk": [
            "未显示明显的安全性风险"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H4",
        "score": 0.61,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.7,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.2
        },
        "graph_signals": {
          "support_weight": 1.35,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Niacin 常用于调节脂质水平，并与疾病相关"
          ],
          "safety_risk": [
            "未显示明显的安全性风险"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H5",
        "score": 0.53,
        "components": {
          "mechanism_fit": 0.65,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.6,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.3
        },
        "graph_signals": {
          "support_weight": 1.25,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Estrogens 已知可以影响脂质代谢，间接可能与疾病相关"
          ],
          "safety_risk": [
            "潜在的安全性风险未得到充分验证"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H6",
        "score": 0.55,
        "components": {
          "mechanism_fit": 0.6,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.6,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.2
        },
        "graph_signals": {
          "support_weight": 1.1,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Thiazolidinediones 有调节脂质的作用，可能与疾病相关"
          ],
          "safety_risk": [
            "未显示明显的安全性风险"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H7",
        "score": 0.54,
        "components": {
          "mechanism_fit": 0.55,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.6,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.2
        },
        "graph_signals": {
          "support_weight": 1.05,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Sodium-glucose cotransporter-2 inhibitors 可能影响代谢通路，间接与疾病相关"
          ],
          "safety_risk": [
            "未显示明显的安全性风险"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H8",
        "score": 0.52,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.6,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.3
        },
        "graph_signals": {
          "support_weight": 0.9,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Corticosteroids 已知对脂肪代谢有影响，但效果复杂"
          ],
          "safety_risk": [
            "潜在安全风险需进一步评估"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H9",
        "score": 0.5,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.6,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.3
        },
        "graph_signals": {
          "support_weight": 0.75,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Bosentan 有可能影响甘油三酯代谢，但尚无明确的证据"
          ],
          "safety_risk": [
            "潜在安全风险需进一步评估"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H10",
        "score": 0.49,
        "components": {
          "mechanism_fit": 0.45,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.6,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.3
        },
        "graph_signals": {
          "support_weight": 0.7,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Glitazones 已知有调节脂质作用，但证据不充分"
          ],
          "safety_risk": [
            "潜在安全风险需进一步评估"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H11",
        "score": 0.47,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.6,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.3
        },
        "graph_signals": {
          "support_weight": 0.65,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Beta-blockers 已知对脂质有一定调节作用，但证据不明确"
          ],
          "safety_risk": [
            "潜在安全风险需进一步评估"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H12",
        "score": 0.46,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.6,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.3
        },
        "graph_signals": {
          "support_weight": 0.6,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Progestins 在脂质代谢中的影响尚需更多支持"
          ],
          "safety_risk": [
            "潜在安全风险需进一步评估"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      }
    ],
    "ranking": [
      "H2",
      "H1",
      "H4",
      "H3",
      "H6",
      "H7",
      "H5",
      "H8",
      "H9",
      "H10",
      "H11",
      "H12"
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_gemfibrozil",
          "type": "Drug",
          "label": "Gemfibrozil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_fenofibrate",
          "type": "Drug",
          "label": "Fenofibrate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_clofibrate",
          "type": "Drug",
          "label": "Clofibrate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_niacin",
          "type": "Drug",
          "label": "Niacin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_estrogens",
          "type": "Drug",
          "label": "Estrogens",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_thiazolidinediones",
          "type": "Drug",
          "label": "Thiazolidinediones",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sodium_glucose_cotransporter_2_inhibitors",
          "type": "Drug",
          "label": "Sodium-glucose cotransporter-2 inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_bosentan",
          "type": "Drug",
          "label": "Bosentan",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_glitazones",
          "type": "Drug",
          "label": "Glitazones",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_beta_blockers",
          "type": "Drug",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_progestins",
          "type": "Drug",
          "label": "Progestins",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Disease_hypertriglyceridaemia",
          "type": "Disease",
          "label": "Severe hypertriglyceridaemia",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_tg pathway",
          "type": "Pathway",
          "label": "Triglyceride Metabolism Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_lipid_modulation",
          "type": "Pathway",
          "label": "Lipid Modulation Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Gemfibrozil",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Fenofibrate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Clofibrate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Niacin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Estrogens",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Thiazolidinediones",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Sodium-glucose cotransporter-2 inhibitors",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Bosentan",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Glitazones",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Progestins",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_gemfibrozil",
          "target": "n_tg pathway",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知作用于甘油三酯代谢"
        },
        {
          "source": "drug_fenofibrate",
          "target": "n_tg pathway",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知作用于甘油三酯代谢"
        },
        {
          "source": "drug_clofibrate",
          "target": "n_tg pathway",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "已知作用于甘油三酯代谢"
        },
        {
          "source": "drug_niacin",
          "target": "n_lipid_modulation",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "常用于调节脂质水平"
        },
        {
          "source": "drug_estrogens",
          "target": "n_lipid_modulation",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "已知可以影响脂质代谢"
        },
        {
          "source": "drug_thiazolidinediones",
          "target": "n_lipid_modulation",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "有调节脂质的作用"
        },
        {
          "source": "drug_sodium_glucose_cotransporter_2_inhibitors",
          "target": "n_lipid_modulation",
          "relation": "acts_on",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "可能影响代谢通路"
        },
        {
          "source": "drug_corticosteroids",
          "target": "n_lipid_modulation",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "已知对脂肪代谢有影响"
        },
        {
          "source": "drug_bosentan",
          "target": "n_tg pathway",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "有可能影响甘油三酯代谢"
        },
        {
          "source": "drug_glitazones",
          "target": "n_lipid_modulation",
          "relation": "acts_on",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "已知有调节脂质作用"
        },
        {
          "source": "drug_beta_blockers",
          "target": "n_lipid_modulation",
          "relation": "acts_on",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "已知对脂质有一定调节作用"
        },
        {
          "source": "drug_progestins",
          "target": "n_lipid_modulation",
          "relation": "acts_on",
          "weight": 0.35,
          "agent": "Proponent",
          "rationale": "在脂质代谢中的影响尚需更多支持"
        },
        {
          "source": "n_tg pathway",
          "target": "Disease_hypertriglyceridaemia",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "甘油三酯代谢与疾病直接相关"
        },
        {
          "source": "n_lipid_modulation",
          "target": "Disease_hypertriglyceridaemia",
          "relation": "involved_in",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "脂质调节与该病损紧密相关"
        }
      ],
      "round_index": 4
    },
    "history": {
      "round": 4
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_fenofibrate",
          "name": "Fenofibrate"
        },
        "score": 0.64,
        "graph_snapshot_ref": "GE_H2_round4",
        "key_assumptions": [
          "Fenofibrate 可有效作用于甘油三酯代谢",
          "未显示明显的安全性风险"
        ],
        "caveats": [
          "对于特定患者群体的长期效果需要进一步研究"
        ],
        "confidence": "high"
      },
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_gemfibrozil",
          "name": "Gemfibrozil"
        },
        "score": 0.63,
        "graph_snapshot_ref": "GE_H1_round4",
        "key_assumptions": [
          "Gemfibrozil 明确影响甘油三酯水平",
          "未显示明显的安全性风险"
        ],
        "caveats": [
          "需要注意与其他药物的潜在相互作用"
        ],
        "confidence": "high"
      },
      {
        "hypothesis_id": "H4",
        "candidate": {
          "id": "drug_niacin",
          "name": "Niacin"
        },
        "score": 0.61,
        "graph_snapshot_ref": "GE_H4_round4",
        "key_assumptions": [
          "Niacin 能调节脂质水平并对疾病有积极影响"
        ],
        "caveats": [
          "需要进行个体化评估以确定安全性"
        ],
        "confidence": "high"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug → Triglyceride Metabolism Pathway → Severe hypertriglyceridaemia",
          "reason": "存在明确的机制链路且已被多次验证"
        }
      ],
      "remaining_gaps": [
        "尚未充分评估 Estrogens 和其他药物的安全性及有效性"
      ]
    },
    "seed_retrospective": {
      "batches": [
        {
          "round": 1,
          "seeds": [
            "A",
            "B"
          ],
          "impact_summary": "引入了基础药物及其机制，形成基础网络"
        },
        {
          "round": 2,
          "seeds": [
            "C",
            "D"
          ],
          "impact_summary": "进一步补全了药物与疾病间的连结，path_disjointness显著提升"
        }
      ],
      "lessons": [
        "应重视对新引入药物的安全性评估",
        "药物间相互作用的关注是不可忽视的"
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "应将长期安全性与疗效纳入关注，重点评估潜在的药物相互作用。"
      },
      {
        "role": "Skeptic",
        "patch": "需提出对特定药物长期使用后效果和风险的预警。"
      },
      {
        "role": "Explorer",
        "patch": "优先关注直接影响甘油三酯水平的药物，避免不相关机制的引入。"
      }
    ],
    "heuristics": [
      {
        "when": "面临甘油三酯水平升高的患者",
        "then": "优先选择已知有效药物并仔细评估其安全性。"
      },
      {
        "when": "考虑长期治疗",
        "then": "需要识别与代谢相关的药物和其副作用。"
      }
    ]
  }
}